Rabies in depth.

Overview

Rabies is a viral zoonotic encephalitis caused by rabies virus — a negative-sense single-stranded RNA virus of the genus Lyssavirus in the family Rhabdoviridae. Rabies is transmitted through the saliva of infected animals — primarily through bites, but also through scratches or licks on broken skin or mucous membranes. Once virus reaches the central nervous system and symptoms develop, rabies is virtually invariably fatal: the case fatality rate exceeds 99%, making it the most uniformly lethal infectious disease in human medicine.

WHO estimates approximately 59,000 people die from rabies each year, with the vast majority (99%) dying in low- and middle-income countries in Africa and Asia. Dogs are responsible for approximately 99% of human rabies deaths globally. Children aged 5–14 years are disproportionately affected — they are more likely to be bitten, to receive severe bites to the head and face, and less likely to receive PEP due to parental unawareness of the risk. India alone accounts for approximately 36% of global rabies deaths.

The fundamental paradox of rabies is that it is both entirely preventable and almost always fatal — yet it continues to kill tens of thousands each year because of inadequate access to post-exposure prophylaxis (PEP), lack of awareness about bite wound washing, and insufficient dog vaccination programs. Every rabies death represents a failure of the public health system to deliver available preventive tools. The WHO "Zero by 30" initiative aims to eliminate human deaths from dog-mediated rabies by 2030 through mass dog vaccination and universal PEP access.

History & Origin

Rabies is one of the oldest documented human diseases — described in ancient Mesopotamian and Egyptian texts, as well as by Aristotle, Celsus, and other classical scholars. The Greek word "lyssa" (madness) became the name of the virus genus. Louis Pasteur developed the first rabies vaccine in 1885, successfully treating 9-year-old Joseph Meister who had been severely bitten by a rabid dog — one of the most dramatic moments in the history of medicine. Pasteur's vaccine was a major milestone in the germ theory era and demonstrated that protective immunity could be induced after exposure.

Modern cell-culture vaccines (HDCV, PCECV, PVRV) replaced the earlier nerve tissue vaccines (which caused neurological complications) from the 1970s onward. Mass dog vaccination programs have eliminated dog-mediated rabies from Western Europe, most of the Americas (except parts of Latin America), Japan, Australia, and New Zealand. These achievements demonstrate that rabies can be controlled — but sustained investment in dog vaccination programs is essential.

Transmission

Rabies is transmitted almost exclusively through contact of infectious saliva with broken skin or mucous membranes — primarily via animal bites.

• Animal bites: The predominant route. Dogs cause approximately 99% of human rabies deaths globally. Other important reservoirs: bats (primary source in the Americas and increasingly globally), foxes, wolves, jackals, raccoons, skunks, and mongoose.
• Scratches and licks on broken skin: Saliva contact with abraded skin or mucous membranes can transmit virus, though bites represent the highest risk. Deep puncture wounds and multiple bites are highest risk.
• Bite site matters: Head, neck, and face bites have a shorter incubation period because virus travels a shorter distance to the brain. Bites to hands have intermediate risk; bites to legs/feet have longer incubation periods.
• Bat exposures: Bat bites may be imperceptible. Any person who wakes up to find a bat in the room, or has had unrecognized contact with a bat, should receive PEP assessment.
• NOT transmitted by: Petting an infected animal; contact with blood, urine, or feces; casual human-to-human contact. Person-to-person transmission is extremely rare (documented only through corneal and organ transplants).

Symptom Timeline

The incubation period is typically 1–3 months but ranges from less than 1 week to over a year. Once symptoms appear, death typically follows within 2–10 days without intensive care support.

Diagnosis

Rabies diagnosis is challenging because no reliable diagnostic test can confirm infection during the incubation period. Antemortem diagnosis in living patients uses multiple tests simultaneously:

• Nuchal skin biopsy: Detection of rabies antigen by direct fluorescent antibody (DFA) or RT-PCR in hair follicle nerve endings from nuchal skin (back of neck). Sensitivity ~70–80%.
• Saliva RT-PCR: Detects rabies virus RNA in saliva. Positive in 50–60% of cases.
• CSF RT-PCR: Low sensitivity but specific; useful if other tests equivocal.
• Serum/CSF serology: Detection of rabies-neutralizing antibodies in CSF (virtually diagnostic of rabies infection in unvaccinated person with encephalitis).
• Brain biopsy/post-mortem: DFA on brain tissue is the gold standard — Negri bodies (intracytoplasmic inclusions in neurons) are pathognomonic on H&E staining but DFA is more sensitive.
• Clinical diagnosis: Encephalitis + hydrophobia + aerophobia + bite history in endemic area is sufficient for clinical diagnosis and PEP initiation.

Treatment

There is no proven effective treatment for clinical rabies. Management is palliative:

• Intensive supportive care: sedation, analgesia, mechanical ventilation for respiratory failure
• The "Milwaukee Protocol" (induced coma with ketamine, midazolam, antiviral drugs, and amantadine) has been used with very rare survivors — the overall evidence base is insufficient to recommend it as standard care. Most attempted applications have been unsuccessful.
• Palliative sedation may be appropriate to relieve suffering in confirmed rabies cases where curative treatment is not available or family declines ICU care
• The only effective intervention is prevention — PEP before symptoms develop

Prevention & Vaccines

Post-Exposure Prophylaxis (PEP) — Critical After Bite

• Step 1 — Wound washing: Immediately wash with soap and water for 15 minutes — reduces risk by up to 90%. Then apply antiseptic (70% alcohol or iodine solution).
• Step 2 — Rabies vaccine: Modern cell-culture vaccines (HDCV, PCECV, PVRV) given as 4 doses on Days 0, 3, 7, 14 for unvaccinated persons (WHO updated schedule also accepts 4-dose 2-site intradermal regimen). Previously vaccinated: 2 doses on Days 0 and 3 only.
• Step 3 — Rabies Immune Globulin (RIG): For Category III exposures (bites penetrating skin, scratches that bleed, mucous membrane exposure) in unvaccinated persons — infiltrated into and around the wound on Day 0. Human RIG (HRIG) or equine RIG (ERIG) used.

Pre-Exposure Prophylaxis (PrEP)

• Recommended for travelers to highly endemic areas, veterinarians, wildlife workers, laboratory workers, and spelunkers
• 3 doses on Days 0, 7, 21 or 28 — provides background immunity; does not eliminate need for PEP after exposure but removes need for RIG and reduces number of PEP doses required

Dog Vaccination — The Key to Elimination

• Mass dog vaccination achieving ≥70% coverage eliminates dog-mediated rabies — as demonstrated in Western Europe, Americas, and Japan
• WHO "Zero by 30" strategy targets elimination of human deaths from dog-mediated rabies by 2030 through combined dog vaccination and PEP access

Global Impact

Rabies kills approximately 59,000 people annually, with over 95% of deaths occurring in Africa and Asia. India accounts for approximately 36% of global rabies deaths (~21,000 per year) — the world's highest national burden. The disease disproportionately kills children: 40% of rabies victims are under 15 years old, reflecting children's greater risk of severe dog bites, higher bite-to-face risk, and lower likelihood of receiving timely PEP.

The economic burden of rabies is enormous: WHO estimates the global economic cost at approximately $8.6 billion annually, including direct costs (PEP, hospitalization) and indirect costs (premature death, loss of livestock). PEP, while highly effective, costs $40–300 per course depending on the country and vaccine type — placing it out of reach for many who need it most.

Significant progress has been made in some regions — Latin America dramatically reduced dog-mediated rabies deaths through the PAHO continental rabies elimination program, reducing human deaths from over 300/year in the 1980s to fewer than 20 by 2015. This demonstrates the feasibility of the "Zero by 30" target, but requires sustained political commitment, funding, and health system strengthening.

Country-Specific Information

India: India has the world's highest rabies burden — approximately 18,000–20,000 deaths per year, representing ~36% of global deaths. Street dogs are the primary vector. Access to PEP, particularly rabies immune globulin (RIG), remains a critical challenge. India's National Rabies Control Programme aims to scale up mass dog vaccination and improve PEP availability.

China: China has the second or third highest rabies burden globally. Campaigns to control dog rabies, including dog cull programs (controversial) and mass vaccination, have been implemented in high-risk provinces. Despite progress, thousands of deaths still occur annually, primarily in rural areas with poor PEP access.

Tanzania: Tanzania is one of Africa's highest-burden rabies countries. Innovative programs by the Serengeti Health Initiative have demonstrated that mass dog vaccination campaigns can dramatically reduce human rabies deaths. Tanzania's Pemba Island was declared rabies-free in 2010 following sustained dog vaccination — a proof-of-concept for island rabies elimination.

Indonesia: Bali, Flores, and several other Indonesian islands have experienced ongoing dog-mediated rabies outbreaks. Bali's 2008–2009 outbreak, following the introduction of rabies to the previously rabies-free island, infected hundreds and killed over 100 people, demonstrating the catastrophic consequences of a single introduction to an unimmunized dog population.

Frequently Asked Questions

Sources & Citations

Related Diseases